BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37611636)

  • 1. Bone Metastases in Patients with Pancreatic NETs: Prevalence and Prognosis.
    Mathew A; Fendler WP; Theysohn J; Herrmann K; Führer D; Lahner H
    Horm Metab Res; 2023 Dec; 55(12):827-834. PubMed ID: 37611636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor Prognosis Associated With Osteolytic Morphology.
    Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.
    Ayala-Ramirez M; Palmer JL; Hofmann MC; de la Cruz M; Moon BS; Waguespack SG; Habra MA; Jimenez C
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1492-7. PubMed ID: 23436918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance.
    Scharf M; Petry V; Daniel H; Rinke A; Gress TM
    Neuroendocrinology; 2018; 106(1):30-37. PubMed ID: 28152537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases.
    Paiella S; Landoni L; Tebaldi S; Zuffante M; Salgarello M; Cingarlini S; D'Onofrio M; Parisi A; Deiro G; Manfrin E; Bianchi B; Montagnini G; Crinò SF; Bassi C; Salvia R
    Neuroendocrinology; 2022; 112(2):143-152. PubMed ID: 33508821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma.
    Xu JY; Murphy WA; Milton DR; Jimenez C; Rao SN; Habra MA; Waguespack SG; Dadu R; Gagel RF; Ying AK; Cabanillas ME; Weitzman SP; Busaidy NL; Sellin RV; Grubbs E; Sherman SI; Hu MI
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4871-4877. PubMed ID: 27662441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
    Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
    Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic imaging in MEN1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
    Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
    Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and skeletal-related events in patients with bone metastasis from gastric cancer.
    Imura Y; Tateiwa D; Sugimoto N; Inoue A; Wakamatsu T; Outani H; Tanaka T; Tamiya H; Yagi T; Naka N; Okawa S; Tabuchi T; Takenaka S
    Mol Clin Oncol; 2020 Oct; 13(4):31. PubMed ID: 32765878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
    Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
    J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
    Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
    Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term disability in solid tumor patients with bone metastases and skeletal-related events.
    Qian Y; Song X; Zhang K; Balakumaran A; Arellano J
    J Med Econ; 2015 Mar; 18(3):210-8. PubMed ID: 25426582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone metastases in gastrointestinal cancer.
    Portales F; Thézenas S; Samalin E; Assenat E; Mazard T; Ychou M
    Clin Exp Metastasis; 2015 Jan; 32(1):7-14. PubMed ID: 25381591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Bone Metastases by
    Tian R; Xie Q; Yu F; Du C; Yao X; Zang S; Zhang C; Zhang P; Shao G; Yang Z; Wang F; Yu J
    Contrast Media Mol Imaging; 2022; 2022():1750132. PubMed ID: 36447752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metastases from differentiated thyroid carcinoma: heterogenous tumor response to radioactive Iodine therapy and overall survival.
    Jannin A; Lamartina L; Moutarde C; Djennaoui M; Lion G; Chevalier B; Vantyghem MC; Deschamps F; Hadoux J; Baudin E; Schlumberger M; Leboulleux S; Do Cao C
    Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2401-2413. PubMed ID: 35149914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating hsa-miR-5096 predicts
    Bocchini M; Tazzari M; Ravaioli S; Piccinini F; Foca F; Tebaldi M; Nicolini F; Grassi I; Severi S; Calogero RA; Arigoni M; Schrader J; Mazza M; Paganelli G
    Front Oncol; 2023; 13():1136331. PubMed ID: 37287922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors.
    Calabrò D; Argalia G; Ambrosini V
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33297381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis.
    Garcia-Torralba E; Spada F; Lim KHJ; Jacobs T; Barriuso J; Mansoor W; McNamara MG; Hubner RA; Manoharan P; Fazio N; Valle JW; Lamarca A
    Cancer Treat Rev; 2021 Mar; 94():102168. PubMed ID: 33730627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.